Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients

Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients

Abstract Hematopoietic stem cell transplant (HSCT) recipients are at high-risk for severe COVID-19 and have altered immune responses to vaccination. We sought to evaluate the dynamics of immune response to BNT162b2 mRNA vaccine in HSCT recipients. We systematically proposed vaccination with BNT162b2...

Full description

Bibliographic Details
Main Authors: Mathieu Leclerc, Rabah Redjoul, Anne Le Bouter, Florence Beckerich, Christine Robin, Vincent Parinet, Cécile Pautas, Dehbia Menouche, Selwa Bouledroua, Lydia Roy, Ludovic Cabanne, Yakout Nait-Sidenas, Slim Fourati, Sébastien Maury
Format: Article
Language:English
Published: BMC 2022-03-01
Series:Journal of Hematology & Oncology
Subjects:
SARS-CoV-2
Hematopoietic stem cell transplantation
Immune response
mRNA vaccine
COVID-19
Online Access:https://doi.org/10.1186/s13045-022-01250-2

Internet

https://doi.org/10.1186/s13045-022-01250-2

Similar Items